|
Cardiovascular Pharmacology
Citations 491-500 of 640 total displayed.
|
Past content
(since Jan 1999):
|
- Scientific Contributions
Efficacy of Eplerenone Added to Renin-Angiotensin Blockade in Hypertensive Patients
- Henry Krum, Hector Nolly, Diane Workman, Weizhong He, Barbara Roniker, Scott Krause, and Kaffa Fakouhi
Hypertension published July 1, 2002, doi:10.1161/01.HYP.0000025146.19104.FE
[Abstract]
- Scientific Contributions
Endogenous Endothelin-1 Limits Exercise-Induced Vasodilation in Hypertensive Humans
- Carmel M. McEniery, Ian B. Wilkinson, David G. Jenkins, and David J. Webb
Hypertension published July 1, 2002, doi:10.1161/01.HYP.0000024218.04872.F3
[Abstract]
- Scientific Contributions
KDR (VEGF Receptor 2) Is the Major Mediator for the Hypotensive Effect of VEGF
- Bing Li, Annie K. Ogasawara, Renhui Yang, Wei Wei, Guo-Wei He, Thomas F. Zioncheck, Stuart Bunting, Abraham M. de Vos, and Hongkui Jin
Hypertension 2002;39:1095-1100, doi:10.1161/01.HYP.0000018588.56950.7A
[Abstract]
[Full text]
- Scientific Contributions
Cardiovascular Effects of Nasal and Transdermal Nicotine and Cigarette Smoking
- Neal L. Benowitz, Anna Hansson, and Peyton Jacob, III
Hypertension 2002;39:1107-1112, doi:10.1161/01.HYP.0000018825.76673.EA
[Abstract]
[Full text]
- Scientific Contributions
Bradykinin Improves Left Ventricular Diastolic Function Under Long-Term Angiotensin-Converting Enzyme Inhibition in Heart Failure
- Masanori Fujii, Atsuyuki Wada, Takayoshi Tsutamoto, Masato Ohnishi, Takahiro Isono, and Masahiko Kinoshita
Hypertension 2002;39:952-957, doi:10.1161/01.HYP.0000015613.78314.9E
[Abstract]
[Full text]
- Scientific Contributions
Neuronal NO Mediates Cerebral Vasodilator Responses to K+ in Hypertensive Rats
- Sophocles Chrissobolis, James Ziogas, Colin R. Anderson, Yi Chu, Frank M. Faraci, and Christopher G. Sobey
Hypertension 2002;39:880-885, doi:10.1161/01.HYP.0000013056.74554.CE
[Abstract]
[Full text]
- Scientific Contributions
Effects of Celecoxib on Ambulatory Blood Pressure in Hypertensive Patients on ACE Inhibitors
- William B. White, Jeffrey Kent, Addison Taylor, Kenneth M. Verburg, James B. Lefkowith, and Andrew Whelton
Hypertension 2002;39:929-934, doi:10.1161/01.HYP.0000014323.99765.16
[Abstract]
[Full text]
- Scientific Contributions
Exaggerated Hypotensive Effect of Vascular Endothelial Growth Factor in Spontaneously Hypertensive Rats
- Renhui Yang, Annie K. Ogasawara, Thomas F. Zioncheck, Zhen Ren, Guo-Wei He, Geralyn G. DeGuzman, Nicolas Pelletier, Ben-Quan Shen, Stuart Bunting, and Hongkui Jin
Hypertension 2002;39:815-820, doi:10.1161/hy0302.105398
[Abstract]
[Full text]
- Scientific Contributions
Effect of Endothelin Blockade on Basal and Stimulated Forearm Blood Flow in Patients With Essential Hypertension
- Paul Martin, Daniel Ninio, and Henry Krum
Hypertension 2002;39:821-824, doi:10.1161/hy0302.105222
[Abstract]
[Full text]
- Scientific Contributions
Angiotensinogen and Its Cleaved Derivatives Inhibit Angiogenesis
- Jérôme Célérier, Amauri Cruz, Noël Lamandé, Jean-Marie Gasc, and Pierre Corvol
Hypertension 2002;39:224-228, doi:10.1161/hy0202.103441
[Abstract]
[Full text]
|
|
